Flagship Biosciences partners with Animal Health Consulting, based in Prescott, Arizona. to deliver quantitative pathology in the veterinary health market. Together these two firms led by veterinarians can provide a unique approach in this specialized market segment. Animal Health Consulting has years of experience in veterinary contract research, technology assessment, clinical trials, business development, marketing and sales of drugs, devices, vaccines, biologics, diagnostics, stem cells, and nutraceutical products to the animal health market. Flagship can quickly and cost-effectively make efficacy and toxicity measurements in tissue, using state-of-the-art digital pathology and imaging techniques and delivered and supervised by board-certified veterinary pathologists.
Development of drugs, biologics and devices in the animal healthcare market closely mirrors human therapeutic development, but requires dedicated veterinary expertise. Many venture-led pharmaceutical firms are realizing the opportunities in the animal health market, where the product development timelines are shorter and one can get faster feedback on both efficacy and toxicology, while improving the lives of animals with innovative products. Similar to the human health market, animal health drug and biologics firms require data on efficacy and toxicology in the local tissue environment. Flagship’s industry-leading quantitative pathology and multiplexed IHC approaches have many applications in delivering data faster in animal health.
Please contact us about this unique approach to making pathology assessment in animal health a quantitative discipline.
